David S Hong

67PUBLICATIONS

529CO-AUTHORS

Predictive and prognostic markersMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (67)

Sort by Publication Date:

|Jun 04, 2026

Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications.

|May 06, 2026

<i>NTRK</i> Gene Fusions: A Compendium of Fusion Partners and Tumor Types.

|Mar 26, 2026

Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Jan 20, 2026

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Niamh Coleman, Zihan Wei, A John Iafrate

|Jan 08, 2026

From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials.

Niamh Coleman, R Donald Harvey, David S Hong

|Dec 22, 2025

Master Protocol Design With Hybrid Control for Efficient Early-Phase Trial Consolidation.

Alexander M Kaizer, Xiaojiang Zhan, Eric Baron

Pageof 12

Frequent Collaborators

14 joint publications

Vivek Subbiah

13 joint publications

Aung Naing

11 joint publications

Janku Filip

11 joint publications

Funda Meric-Bernstam

Sarina Piha-Paul

Siqing Fu

Jordi Rodon Ahnert

Timothy A Yap

Jason Roszik

John V Heymach

Frequent Collaborators

14 joint publications

Vivek Subbiah

13 joint publications

Aung Naing

11 joint publications

Janku Filip

11 joint publications

Funda Meric-Bernstam